Recombinant Human CXCL11/I-TAC

Name Recombinant Human CXCL11/I-TAC
Supplier R&D Systems
Catalog 672-IT-025
Category Protein
Nature Recombinant
Source E. coli-derived, Phe22-Phe94
Purity >97%, by SDS-PAGE under reducing conditions and visualized by silver stain.
SwissProt/Accession O14625
Gene CXCL11
Supplier Page Shop

Product References

Widespread potential for growth-factor-driven resistance to anticancer kinase - Widespread potential for growth-factor-driven resistance to anticancer kinase

Wilson TR, Fridlyand J, Yan Y, Penuel E, Burton L, Chan E, Peng J, Lin E, Wang Y, Sosman J, Ribas A, Li J, Moffat J, Sutherlin DP, Koeppen H, Merchant M, Neve R, Settleman J. Nature. 2012 Jul 26;487(7408):505-9.

CCL19 is a specific ligand of the constitutively recycling atypical human - CCL19 is a specific ligand of the constitutively recycling atypical human

Leick M, Catusse J, Follo M, Nibbs RJ, Hartmann TN, Veelken H, Burger M. Immunology. 2010 Apr;129(4):536-46.

CXCR7 protein is not expressed on human or mouse leukocytes. - CXCR7 protein is not expressed on human or mouse leukocytes.

Berahovich RD, Zabel BA, Penfold ME, Lewen S, Wang Y, Miao Z, Gan L, Pereda J, Dias J, Slukvin II, McGrath KE, Jaen JC, Schall TJ. J Immunol. 2010 Nov 1;185(9):5130-9.

Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally - Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally

Loos T, Mortier A, Gouwy M, Ronsse I, Put W, Lenaerts JP, Van Damme J, Proost P. Blood. 2008 Oct 1;112(7):2648-56.

Infiltrated neutrophils acquire novel chemokine receptor expression and chemokine - Infiltrated neutrophils acquire novel chemokine receptor expression and chemokine

Hartl D, Krauss-Etschmann S, Koller B, Hordijk PL, Kuijpers TW, Hoffmann F, Hector A, Eber E, Marcos V, Bittmann I, Eickelberg O, Griese M, Roos D. J Immunol. 2008 Dec 1;181(11):8053-67.

Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7 - Proteolytic processing of CXCL11 by CD13/aminopeptidase N impairs CXCR3 and CXCR7

Proost P, Mortier A, Loos T, Vandercappellen J, Gouwy M, Ronsse I, Schutyser E, Put W, Parmentier M, Struyf S, Van Damme J. Blood. 2007 Jul 1;110(1):37-44. Epub 2007 Mar 15.

Down-modulation of CXCR3 surface expression and function in CD8+ T cells from - Down-modulation of CXCR3 surface expression and function in CD8+ T cells from

Winter D, Moser J, Kriehuber E, Wiesner C, Knobler R, Trautinger F, Bombosi P, Stingl G, Petzelbauer P, Rot A, Maurer D. J Immunol. 2007 Sep 15;179(6):4272-82.

Normalizing the bone marrow microenvironment with p38 inhibitor reduces multiple - Normalizing the bone marrow microenvironment with p38 inhibitor reduces multiple

Nguyen AN, Stebbins EG, Henson M, O'Young G, Choi SJ, Quon D, Damm D, Reddy M, Ma JY, Haghnazari E, Kapoun AM, Medicherla S, Protter A, Schreiner GF, Kurihara N, Anderson J, Roodman GD, Navas TA, Higgins LS. Exp Cell Res. 2006 Jun 10;312(10):1909-23. Epub 2006 Apr 4.

Plasmacytoid dendritic cell recruitment by immobilized CXCR3 ligands. - Plasmacytoid dendritic cell recruitment by immobilized CXCR3 ligands.

Kohrgruber N, Groger M, Meraner P, Kriehuber E, Petzelbauer P, Brandt S, Stingl G, Rot A, Maurer D. J Immunol. 2004 Dec 1;173(11):6592-602.

Enhanced generation of helper T type 1 and 2 chemokines in allergen-induced - Enhanced generation of helper T type 1 and 2 chemokines in allergen-induced

Liu L, Jarjour NN, Busse WW, Kelly EA. Am J Respir Crit Care Med. 2004 May 15;169(10):1118-24. Epub 2004 Mar 4.